“Four recent observational studies have found that people taking GLP-1 drugs tend to have better cancer outcomes, including lower rates of tumor progression and mortality, as well as lower rates of breast cancer diagnosis. The studies do not attempt to show causation; they are simply promising observations and signals for further research,” reports The Doomslayer. The weight-loss drugs Ozempic and Wegovy are GLP-1 drugs.
The Wall Street Journal reports:
Read Full Article: https://libertyunyielding.com/2026/05/30/people-who-take-ozempic-have-better-cancer-outcomes-studies-say/
